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A protective effect of calcium and/or dairy products on colorectal cancer has been reported in 
epidemiological studies but the ﬁndings are considered inconsistent. In particular, it is unclear whether 
they act at a particular step of the adenoma-carcinoma sequence. To investigate the effect of dairy product 
consumption and dietary calcium, vitamin D and phosphorus intake on the adenoma-carcinoma sequence 
in the French E3N-EPIC prospective study. The population for the study of risk factors for adenomas was 
composed of 516 adenoma cases, including 175 high-risk adenomas, and of 4,804 polyp-free subjects 
conﬁrmed by colonoscopy. The population for the colorectal cancer study was composed of 172 cases and 
67,312 cancer-free subjects. Diet was assessed using a self-administered questionnaire completed at 
baseline. There was a trend of decreasing risk of both adenoma trend5 0.04) and cancer (ptrend50.08) with 
increasing calcium intake, with RRs for adenoma and cancer of 0.80 (IC 95%50.62– 1.03) and 0.72 (95% 
CI50.47–1.10), respectively, in the fourth quartile compared to the ﬁrst. A protective effect of dairy prod-
ucts on adenoma (RRQ4 vs.Q15 0.80, 95% CI50.62-1.05, ptrend5 0.04) was observed and of milk 
consumption on colorectal cancer Q4vs.Q15 0.54, 95% CI50.33–0.89, ptrend5 0.09), although the latter 
did not reach signiﬁcance. Phosphorus intake also decreased the risk of adenoma (RRQ4 vs.Q150.70, 95% 
CI50.54–0.90, trend5 0.005). No vitamin D effect was identiﬁed. Our data support the hypothesis that 
calcium, dairy products and phosphorus exert a protective effect at certain steps of the adenoma-
carcinoma sequence.  
 
 
The idea that an intake of calcium and vitamin D might protect against colorectal cancer was ﬁrst 
suggested by Newmark et al.
1
 In experimental studies, low calcium diets have consistently been associated 
with increased cell proliferation and low cell differentiation.
2
 
It has therefore been suggested that calcium 
acts directly on epithelial cell proliferation and differentiation, as well as indirectly by forming insoluble 
soaps with secondary bile acids, although this point has never been formally demonstrated.
2,3
 
Vitamin D 
plays a major role in the homeostasis of calcium and 2 studies have also suggested that it reduces 
epithelial cell proliferation and promotes differentiation.
2,4
 It has been further suggested that 
polymorphisms of the vitamin D receptor (VDR) might modulate this effect.
5
 
However, ﬁndings from epidemiological studies on the relationship between calcium or dairy 
product intake and risk of colorectal adenoma or/and of cancer were judged inconsistent in 2 reviews,
6,7
 
except for a steady protective effect of dairy product reported in cohort studies.
6
 Although a meta-
analysis
8
 
concluded that calcium had no protective effect on colorectal tumours, prospective studies and 
large case-control studies subsequently found a modestly beneﬁcial effect.9-11
 
Recently the Pooling 
                                                 
* Correspondence to: INSERM, Equipe E3N-EPIC, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France. Fax: 
133-1-42-11-40-00. E-mail: clavel@igr.fr  
 
Project, a pooled analysis of 10 prospective studies,
12
 
showed a signiﬁcant protective effect of calcium and 
milk on colorectal cancer risk.  
Additional information has become available from recent intervention trials,
13-15
 
which suggested 
a protective effect of calcium supplementation on the risk of colorectal adenoma recurrence, but the level 
of calcium required for adenoma chemoprevention has yet to be deﬁned. We prospectively studied the 
association between the intake of dietary calcium, phosphorus, vitamin D and/ or dairy products and the 
risk of adenomatous polyps and colorectal cancer among women participating in the E3N-EPIC study.  
 
Material and methods  
Cohort study  
E3N (Etude Epidémiologique de femmes de la Mutuelle Genérale de l’Education Nationale) is a 
prospective cohort study conducted in France to study the risk factors for the most common cancer sites in 
women.
16
 
The cohort was established in 1990 and consisted of 100,000 women living in France, aged 40 
to 65 years at baseline and insured with the Mutuelle Generale de l’Education Nationale, a national health 
insurance scheme for teachers. E3N is also the French part of the EPIC study.
17
 
Dietary habits, reproductive factors, use of hormonal treatments, tobacco consumption, 
anthropometric measurements, personal history of disease, family history of cancer and other factors were 
recorded in self-administered questionnaires completed approximately every 24 months. Each 
questionnaire inquired about the occurrence of personal medical events, in particular of colorectal polyps 
or cancer, since the previous follow-up questionnaire.  
 
Dietary data  
Dietary data were collected between June 1993 and July 1995, using a 2-part questionnaire. The 
ﬁrst part contained questions on frequency of consumption of food groups and the amounts usually 
consumed, while the second included qualitative questions allowing to detail individual foods within the 
food groups. The questionnaire was used to assess the consumption of 208 food items, beverages and 
recipes. It was accompanied by a booklet of photographs illustrating portion sizes.  
Both the questionnaire and the booklet were validated.
18,19
 The validity of the dietary 
questionnaire was assessed using a sample of 115 women, taking as the reference the average of 12 24-hr 
recalls obtained at monthly intervals over a 1-year period. The reproducibility of the 24-hr recall 
questionnaires was also tested. The Spearman’s correlation coefﬁcient for dairy products consumption was 
0.67 for validity and 0.73 for reproducibility. A high proportion of subjects (76% for foods and 72% for 
nutrients) were classiﬁed in the same or adjacent quintile for the dietary questionnaire and the 24-hr 
recalls. The Pearson’s correlation coefﬁcient for calcium intake was 0.38 for validity and 0.75 for 
reproducibility.  
The diet history questionnaire was sent to 95,644 women, with 2 reminders to nonresponders. In 
all, 77,613 completed questionnaires (81.1%) were received.  
After exclusion of 985 questionnaires because of absence of consent to external health follow-up 
by the health insurer in case of dropout, 2,050 questionnaires because of miscoded answers, 8 empty 
questionnaires and 46 duplicate ones, 74,524 questionnaires were available for analysis.  
Women with extreme values (in the top or bottom 1%) for the energy intake/energy requirement 
ratio (calculated taking age, weight and height into account) were excluded. A total of 73,034 women 
were ﬁnally available for analysis. Total dairy products were considered as well as individual products 
(yoghurt, milk, cottage cheese and cheese). The dietary intake of calcium, vitamin D and phosphorus and 
the calcium to phosphorus ratio were analysed using a food composition table derived from the French 
national database
20
.
 
 
 
Cases and noncases  
No mass-screening for colorectal cancer was achieved in France at the time of our study. 
Complete colonoscopy was performed mostly for investigating anemia or bowel symptoms, as well as 
sometimes for screening ﬁrst degree relatives of subjects with colorectal neoplasia. Therefore adenoma 
subjects and adenoma-free controls were selected in the same way. Colorectal cancers were mostly 
diagnosed when symptomatic.  
The risks of adenoma and colorectal cancer were studied separately.  
The adenoma study was based on the 1,933 subjects who had reported diagnosis of a colorectal 
polyp between the return of the dietary questionnaire (1993–1995) and the endpoint of the analysis 
(December 1997). Pathology reports were obtained for 1,892 (97.9%) of these women; 41 of them had a 
tumour of unidentiﬁed histological type, 388 had no tumour, 108 had a colorectal cancer, 387 had 
hyperplastic polyps and 968 had adenomatous polyps. After exclusion of subjects with previous cancer 
(n534), familial adenomatous polyposis (n57), an inﬂammatory bowel disease (n57), a personal history of 
previous adenoma (n5390) or an adenoma diagnosed after the end of follow-up (n514), 516 subjects were 
considered as cases. As adenomas are frequent
21
 
and are mostly asymptomatic tumours, adenoma cases 
were compared to a polyp-free population. Noncases were deﬁned as subjects who were polyp-free at 
endpoint and had never reported a personal history of polyps or cancer. Subjects contributed person-time 
up to the date of diagnosis of an adenomatous polyp, date of cancer of any site (other than basal cell skin 
carcinoma), date of last completed questionnaire, date of death or December 1997, whichever occurred 
ﬁrst. In order to identify nutritional factors involved in adenoma progression, a high-risk adenoma group 
was deﬁned. It covered large adenomas (over 1 cm in diameter), adenomas with severe dysplasia, multiple 
(i.e., 3 or more) adenomas and those with a villous component.
22
 
The population for the adenoma study 
was composed of 516 women with adenomatous polyps, including 175 high-risk adenomas and 4,804 
polyp-free women.  
The colorectal cancer study was based on subjects who had reported diagnosis of a primary 
colorectal cancer between the return of the dietary questionnaire (1993–1995) and June 2000. We 
excluded subjects who had reported a cancer diagnosis before the start of follow-up (n54592), 
nonhistologically conﬁrmed colorectal cancers (n57), a familial polyposis syndrome (n5334), an 
inﬂammatory bowel disease (n5556) and subjects lost to followup after dietary assessment (n561). 
Subjects contributed persontime up to the date of diagnosis of colorectal cancer, date of cancer of any 
other site (other than basal cell skin carcinoma), date of last completed questionnaire, date of death or June 
2000, whichever occurred ﬁrst. 172 women with colorectal cancer and 67,312 women free of colorectal 
cancer were ﬁnally included in the analysis.  
 
Statistical analysis  
The association between dairy products, dietary calcium, phosphorus, the calcium to phosphorus ratio, 
vitamin D and adenomatous polyp or colorectal cancer diagnosis was estimated using Cox proportional 
hazards models. Age at recruitment was used as the primary time variable. Age at diagnosis of 
adenomatous polyps (adenoma study), at diagnosis of colorectal cancer (colorectal cancer study) or at 
censoring date was used as the end-of-study time variable.  
Adjustment for total dietary energy intake was made with the energy-adjusted nutrient intake 
method,
23
 
using residuals of nutrients intakes on total energy (other than from alcohol). For foods, 
adjustment for energy was performed by including energy as a continuous variable in the Cox model.  
Quartiles for each analysis were calculated on the distribution of noncases. For milk and cottage 
cheese, a nonconsumer category was deﬁned (as over 25% of subjects were nonconsumers of these 
products) and consumers were classiﬁed in tertiles. Tests for linear trend were performed using the ordinal 
score. We also tested for potential interaction between calcium and phosphorus.  
To control for potential confounding factors, values were adjusted for body mass index at 
recruitment, total daily alcoholfree energy intake and total daily alcohol intake (all as continuous 
variables), family history of colorectal cancer (yes/no), physical activity (tertile of weekly energy 
expenditure), education level (≤11, 12–13, 14–15, ≥16 years of schooling) and smoking status at baseline 
(ever/never). Further adjustment included calcium or vitamin D supplementation as a treatment for 
osteoporosis (yes/ no), energy-adjusted ﬁbre and folate, consumption of red meat, consumption of 
processed meat and contribution of saturated fatty acids to dietary energy intake.  
All analyses were performed using the SAS software, version 8.2.  
 Results  
Characteristics of the studied populations  
The median follow-up time was 3.7 years in the adenoma study and 6.9 years in the cancer study. Baseline 
characteristics of all groups are presented in Table I. Adenoma cases were older than polyp-free subjects 
(p<0.001): mean 6 SD was 54.4 6 6.7 years for the total adenoma group, 54.9 6 6.7 years for the high-risk 
adenoma group and 52.8 6 6.4 years for the polyp-free group. Adenoma cases were also signiﬁcantly less 
educated (p50.008), consumed more alcohol (p50.005) and had a higher BMI (p50.002) than polyp-free 
subjects. Total energy intake, smoking status and calcium and /or vitamin D supplementation did not dif-
fer signiﬁcantly between adenoma cases and polyp-free subjects. Colorectal cancer cases were 
signiﬁcantly older (p<0.001) and had a higher BMI (p50.03) than cancer-free subjects. They more 
frequently had a history of colorectal cancer in their ﬁrst-degree relatives than the reference population 
(p<0.001).  
 
 
Table I – Baseline characteristics of cases and noncases included in the colorectal adenoma and 
cancer studies: E3N-EPIC study (1993)  
 
 Adenoma study  Colorectal cancer study 
 Polyp-free All adenoma High-risk adenoma  Colorectal cancer-free Colorectal cancer 
N participants   
N person-years 
Age1
 
mean years (sd) 
BMI1mean kg/m2
 
(sd) 
Low level of energy expenditure1
 
(%) 
Familial history of colorectal 
cancer1,2
 
(%) 
Number of years schooling < 12 
years (%) 
Current smokers1
 
(%) 
Ex-smokers1 (%) 
Calcium and/or vitamin D1
 
treatment 
for osteoporosis (%) 
Ethanol1 mean g/day  (sd) 
Energy intake1: mean Kcal/day (sd) 
4,804 
16,489 
52.8 (6.4) 
22.74 (3.14) 
33.14 
30.18 
 
10.41 
 
12.65 
22.49 
3.83 
 
10.84 (13.92) 
2,048.47 (528.24) 
516 
 
54.43(6.7) 
23.213 (3.35) 
35.27 
31.20 
 
15.754 
 
14.60 
23.86 
4.26 
 
12.903
 
(15.93) 
2,026.05 (521.05) 
175 
 
54.93
 
(6.7) 
23.16 (3.43) 
33.71 
33.71 
 
15.34 
 
16.37 
23.98 
3.43 
 
13.963
 
(18.97) 
1,986.60 (519.67) 
 67,312 
425,392 
52.7 (6.6) 
23.01 (3.33) 
33.34 
12.14 
 
11.58 
 
14.25 
23.03 
2.93 
 
11.14 (14.10) 
2,028.98 (537.55) 
172 
 
57.23
 
(6.4) 
23.643 (3.70) 
31.40 
22.094 
 
15.57 
 
13.69 
17.26 
4.65 
 
13.04 (20.82) 
2,055.92 (497.45) 
1 At time of dietary record.–2 In ﬁrst-degree relatives (parents and sibling).–3 p <0.05 for t-test comparing cases (adenomas or cancers) to their 
reference population (polyp-free and cancer-free subjects, respectively).–4
 
p <0.05 for v -test, testing independence of distribution between cases  
and their reference population. 
 
Descriptive statistics of the nutrient intake and dairy products consumption of both reference groups are 
presented in Table II. Intakes of the nutrients studied were higher among polyp-free subjects than among 
cancer-free subjects.  
 
 
Table II – Descriptive statistics of nutrients intakes and food consumption of the two non case populations 
 
 Polyp-free subjects (n=4804)  Cancer-free subjects (n=67312) 
 Mean Standard 
deviation 
10th 
percentile 
1st 
quartile 
Median 3rd 
quartile 
90th 
percentile 
 Mean Standard 
deviation 
10th 
percentile 
1st 
quartile 
Median 3rd 
quartile 
90th 
percentile 
Energy-adjusted nutrient intakes (/day)         
Calcium (mg) 1,034.71 363.65 640.08 785.62 981.67 1226.16 1,499.42  1,014.15 359.55 617.55 766.22 962.63 1,201.81 1,469.18 
Dairy calcium (mg) 594.32 323.85 258.73 370.72 538.25 754.86 1,015.24  578.75 319.31 240.74 359.24 523.03 736.00 979.28 
Phosphorus (mg) 1,413.77 387.23 957.07 1,141.86 1,374.86 1,633.83 1,923.29  1,391.40 388.12 934.31 1121.23 1,352.25 1,613.57 1,898.93 
Vitamin D (g) 2.63 1.29 1.29 1.73 2.37 3.26 4.34  2.61 1.28 1.26 1.72 2.37 3.23 4.25 
Food item (g/day)                
Total dairy products  324.44 200.60 120.48 184.83 280.96 424.29 578.10  316.84 201.30 114.19 179.47 274.72 409.21 564.89 
Milk1 102.81 156.04 - - 26.27 165.47 300.00  100.74 157.90 - - 23.57 151.34 300.00 
Yogurt 91.06 79.65 - 32.29 80.71 129.14 193.71  88.42 78.76 - 32.29 80.71 120.42 193.71 
Cottage cheese2 39.06 52.85 - - 20.85 57.14 107.14  37.44 51.31 - - 19.70 54.93 100.49 
Cheese 55.89 42.07 11.90 27.26 47.76 71.29 115.71  54.61 40.96 11.18 26.67 46.95 70.13 109.03 
1Non-consumers: 42.99% in the adenoma study; 43.7% in the cancer study. 2Non-consumers: 30.6% in the adenoma study; 31.02% in the cancer study. 
 
 
 
Table III - RRs of adenoma, high-risk adenoma and colorectal cancer by quartile of energy-adjusted calcium, total calcium, dairy, 
phosphorus and vitamin D intake. 
 All adenomas High-risk adenomas Colorectal cancer 
Calcium (mg) <785.62 785.62-
981.67 
981.67-
1226.16 
>1226.16 P  for trend <785.62 785.62-
981.67 
981.67-
1226.16 
>1226.16 P  for trend <766.22 766.22-
962.63 
962.63-
1,201.81 
>1,201.81 P  for trend 
Cases (n) 140 141 121 114  46 45 46 38  49 47 39 37  
RR (Age-adjusted) 
(IC 95%) 
1.00 
 
0.96 
(0.76-1.22) 
0.83 
(0.65-1.07) 
0.79 
(0.62-1.01) 
0.03 1.00 
 
0.92 
(0.61-1.39) 
0.92 
(0.61-1.40) 
0.77 
(0.50-1.19) 
0.27 1.00 
 
0.94 
(0.63-1.41) 
0.77 
(0.51-1.18) 
0.70 
(0.46-1.08) 
0.07 
RR (Fully1 adjusted) 
 (IC 95%) 
1.00 
 
0.97 
(0.76-1.22) 
0.83 
(0.65-1.07) 
0.80 
(0.62-1.03) 
0.04 1.00 
 
0.93 
(0.62-1.41) 
0.94 
(0.62-1.42) 
0.80 
(0.52-1.23) 
0.34 1.00 
 
0.94 
(0.63-1.41) 
0.78 
(0.51-1.19) 
0.72 
(0.47-1.10) 
0.08 
Dairy calcium (mg) <370.72 370.72-
538.25 
538.25-
754.86 
>754.86 P  for trend <370.72 370.72-
538.25 
538.25-
754.86 
>754.86 P  for trend <359.24 359.24-
523.03 
523.03-
736.00 
>736.00 P  for trend 
Cases (n) 132 162 108 114  39 61 35 40  45 51 36 40  
RR (Age-adjusted) 
(IC 95%) 
1.00 
 
1.20 
(0.95-1.51) 
0.80 
(0.62-1.03) 
0.85 
(0.66-1.09) 
0.02 1.00 
 
1.50 
(1.00-2.25) 
0.84 
(0.53-1.33) 
0.98 
(0.63-1.52) 
0.30 1.00 
 
1.12 
(0.75-1.69) 
0.78 
(0.50-1.22) 
0.84 
(0.55-1.28) 
0.20 
RR (Fully1 adjusted) 
 (IC 95%) 
1.00 
 
1.20 
(0.95-1.52) 
0.82 
(0.64-1.07) 
0.86 
(0.67-1.11) 
0.04 1.00 
 
1.52 
(1.00-2.28) 
0.89 
(0.56-1.41) 
1.02 
(0.65-1.59) 
0.43 1.00 
 
1.13 
(0.76-1.70) 
0.80 
(0.51-1.25) 
0.86 
(0.56-1.32) 
0.25 
Phosphorus (mg) <1,141.86 1,141.86-
1,374.86 
1,374.86-
1,633.83 
>1,633.83 P  for trend <1,141.86 1,141.86-
1,374.86 
1,374.86-
1,633.83 
>1,633.83 P  for trend <1121.23 1121.23-
1,352.25 
1,352.25-
1,613.57 
>1,613.57 P  for trend 
Cases (n) 143 135 129 109  45 46 44 40  52 41 38 41  
RR (Age-adjusted) 
(IC 95%) 
1.00 
 
0.92 
(0.73-1.17) 
0.88 
(0.69-1.11) 
0.74 
(0.58-0.96) 
0.02 1.00 
 
0.97 
(0.64-1.47) 
0.92 
(0.61-1.40) 
0.84 
(0.55-1.29) 
0.41 1.00 
 
0.79 
(0.52-1.20) 
0.73 
(0.48-1.12) 
0.77 
(0.51-1.15) 
0.18 
RR (Fully1 adjusted) 
 (IC 95%) 
1.00 
 
0.89 
(0.70-1.13) 
0.83 
(0.65-1.06) 
0.70 
(0.54-0.90) 
0.005 1.00 
 
0.93 
(0.61-1.41) 
0.87 
(0.57-1.32) 
0.77 
(0.50-1.19) 
0.23 1.00 
 
0.77 
(0.51-1.17) 
0.70 
(0.46-1.08) 
0.73 
(0.48-1.10) 
0.11 
Vitamin D (g) <1.73 1.73-2.37 2.37-3.26 >3.26 P 
 for trend <1.73 1.73-2.37 2.37-3.26 >3.26 P  for trend <1.72 1.72-2.37 2.37-3.23 >3.23 P  for trend 
Cases (n) 105 158 129 124  38 50 47 40  46 48 37 41  
RR (Age-adjusted) 
(IC 95%) 
1.00 
 
1.51 
(1.18-1.93) 
1.27 
(0.98-1.64) 
1.21 
(0.93-1.57) 
0.43 1.00 
 
1.32 
(0.87-2.02) 
1.28 
(0.83-1.97) 
1.07 
(0.69-1.67) 
0.83 1.00 
 
1.13 
(0.75-1.70) 
0.88 
(0.57-1.35) 
0.94 
(0.61-1.43) 
0.51 
RR (Fully1 adjusted) 
 (IC 95%) 
1.00 
 
1.49 
(1.16-1.91) 
1.25 
(0.96-1.62) 
1.15 
(0.88-1.49) 
0.72 1.00 
 
1.29 
(0.85-1.98) 
1.24 
(0.81-1.91) 
1.00 
(0.64-1.57) 
0.92 1.00 
 
1.11 
(0.74-1.67) 
0.85 
(0.55-1.31) 
0.89 
(0.58-1.36) 
0.37 
1 Adjusted for the following variables at the time of dietary record: educational level, current smoking status, family history of colon cancer, body mass index, physical activity level and  energy and 
alcohol intake. 
Nutrient intake  
The RR of adenomas and colorectal cancer associated with nutrient intake are presented in Table 
III.  
Calcium. The RR of adenoma decreased signiﬁcantly with increasing intake of total dietary 
calcium (p for trend 5 0.04). The fully adjusted RR in the highest quartile of consumption compared to the 
lowest was 0.80 (95% CI 5 0.62–1.03). The effect was similar although nonsigniﬁcant in the high-risk 
adenoma group. Although signiﬁcance was not reached, the RR of colorectal cancer also decreased with 
increasing calcium intake (p for trend 5 0.08), with a RR of 0.72 (95% CI 5 0.47–1.10) in the highest 
quartile compared to the lowest.  
Results for dairy calcium (57.1% of total calcium) were similar but less pronounced.  
Phosphorus. Increasing intake of phosphorus was associated with a signiﬁcant decrease in the RR 
of adenoma (p for trend 5 0.005), with a RR of 0.70 (95% CI 5 0.54–0.90) in the highest quartile 
compared to the lowest. Phosphorus was observed to have a similar effect on high-risk adenomas and 
cancer, although it did not reach statistical signiﬁcance.  
A nonsigniﬁcant decrease in the risk of colorectal cancer was also observed with increasing intake 
of phosphorus (p for trend 5 0.11), with a RR of 0.73 (95% CI 5 0.48–1.10) in the highest quartile of 
intake compared to the lowest. The test for interaction between phosphorus and calcium intake was not 
signiﬁcant. No association was found between the calcium to phosphorus ratio and colorectal tumour risk.  
 
Vitamin D  
No association was found between dietary vitamin D intake and risk of colorectal tumour, with or 
without adjustment for calcium and/or phosphorus intakes.  
 
Dairy products  
The age-adjusted, energy-adjusted and fully adjusted RRs of colorectal tumour according to dairy 
products consumption are shown in Table IV. 
Increasing consumption of total dairy products decreased the RR of adenoma (p for trend < 0.05). 
The fully adjusted RR among subjects in the highest quartile compared to the lowest was 0.80 (95% CI 5 
0.62–1.05). The decrease in risk of both high-risk adenoma and cancer was similar to that observed in the 
analysis of all adenomas but the tests for trend were not statistically signiﬁcant.  
No speciﬁc effect of any dairy product (i.e., milk, yoghurt, cottage cheese or cheese) was 
observed on colorectal tumour risk, except for a protective effect of high milk consumption on colorectal 
cancer (RR50.54, 95% CI 5 0.33–0.89 in the highest tertile compared to nonconsumers).  
After adjustment for calcium or vitamin D supplementation as a treatment for osteoporosis, intake 
of dietary ﬁbre, folate and saturated fatty acids (as percent of total energy intake), consumption of red 
meat and consumption of processed meat, the results were essentially unchanged and are not tabulated.  
 
 
Table IV - RRs of adenoma, high-risk adenoma and colorectal cancer by quartiles or tertiles (versus non-consumers) of consumption of 
total dairy product, milk, yogurt, cottage cheese and cheese consumption. 
 All adenomas High-risk adenomas Colorectal cancer 
Total dairy 
products (g) 
<184.83 184.83-
280.96 
280.96-
424.29 
>424.29 P for 
trend 
<184.83 184.83-
280.96 
280.96-424.29 >424.29 P for 
trend 
<179.47 179.47-
274.72 
274.72-409.21 >409.21 P for 
trend 
Cases (n) 146 145 114 111  50 51 37 37  47 44 43 38  
RR (Age-adjusted) 
(IC 95%) 
1.00 
 
0.99 
(0.78-1.24) 
0.79 
(0.61-1.01) 
0.77 
(0.60-1.00) 
0.02  1.05 
(0.71-1.55) 
0.76 
(0.50-1.18) 
0.80 
(0.51-1.25) 
0.17  0.93 
(0.62-1.41) 
0.88 
(0.58-1.34) 
0.74 
(0.48-1.16) 
0.19 
RR (Fully1 
adjusted) 
 (IC 95%) 
1.00 
 
1.01 
(0.80-1.27) 
0.81 
(0.63-1.05) 
0.80 
(0.62-1.05) 
0.04 1.00 
 
1.07 
(0.72-1.60) 
0.81 
(0.52-1.25) 
0.85 
(0.54-1.33) 
0.28 1.00 
 
0.94 
(0.62-1.43) 
0.90 
(0.59-1.38) 
0.78 
(0.49-1.22) 
0.28 
Milk (g) NC2 <80 80-210 >210 P for 
trend 
NC2 <80 80-210 >210 P for 
trend 
NC2 <79.72 79.72-210 >210 P for 
trend 
Cases (n) 229 104 90 93  81 35 32 27  82 29 42 19  
RR (Age-adjusted) 
(IC 95%) 
1.00 
 
0.99 
(0.78-1.25) 
0.87 
(0.68-1.11) 
0.93 
(0.73-1.18) 
0.33 1.00 
 
0.95 
(0.64-1.41) 
0.88 
(0.58-1.32) 
0.77 
(0.50-1.20) 
0.24 1.00 
 
0.80 
(0.52-1.22) 
1.08 
(0.74-1.56) 
0.53 
(0.32-0.87) 
0.07 
RR (Fully1 
adjusted) 
 (IC 95%) 
1.00 
 
1.01 
(0.80-1.28) 
0.87 
(0.68-1.11) 
0.93 
(0.73-1.19) 
0.36 1.00 
 
0.98 
(0.66-1.46) 
0.91 
(0.60-1.37) 
0.80 
(0.51-1.23) 
0.31 1.00 
 
0.81 
(0.53-1.23) 
1.08 
(0.75-1.57) 
0.54 
(0.33-0.89) 
0.09 
Yogurt (g) <32.29 32.29-80.71 80.71-129.14 >129.14 P for 
trend 
<32.29 32.29-80.71 80.71-129.14 >129.14 P for 
trend 
<32.29 32.29-80.71 80.71-120.42 >120.42 P for 
trend 
Cases (n) 163 110 144 99  61 37 42 35  58 37 40 37  
RR (Age-adjusted) 
(IC 95%) 
1.00 
 
0.89 
(0.69-1.13) 
0.97 
(0.78-1.22) 
0.84 
(0.65-1.07) 
0.28 1.00 
 
0.82 
(0.55-1.24) 
0.77 
(0.52-1.15) 
0.81 
(0.53-1.23) 
0.24 1.00 
 
0.88 
(0.58-1.33) 
0.91 
(0.61-1.37) 
0.80 
(0.53-1.21) 
0.34 
RR (Fully1 
adjusted) 
 (IC 95%) 
1.00 
 
0.91 
(0.72-1.17) 
1.03 
(0.82-1.29) 
0.87 
(0.68-1.13) 
0.52 1.00 
 
0.85 
(0.56-1.29) 
0.82 
(0.55-1.22) 
0.85 
(0.56-1.30) 
0.38 1.00 
 
0.90 
(0.60-1.36) 
0.95 
(0.63-1.42) 
0.82 
(0.54-1.25) 
0.42 
Cottage cheese (g) NC† <22.47 22.47-59.71 >59.71 P for 
trend 
NC† <22.47 22.47-59.71 >59.71 P for 
trend 
NC† <21.43 21.43-57.14 >57.14 P for 
trend 
Cases (n) 160 125 111 120  52 36 40 47  63 40 36 33  
RR (Age-adjusted) 
(IC 95%) 
1.00 
 
1.07 
(0.85-1.36) 
0.93 
(0.73-1.19) 
0.98 
(0.77-1.24) 
0.63 1.00 
 
0.98 
(0.64-1.50) 
1.06 
(0.70-1.61) 
1.20 
(0.81-1.79) 
0.35 1.00 
 
0.88 
(0.59-1.31) 
0.79 
(0.52-1.19) 
0.69 
(0.45-1.06) 
0.07 
RR (Fully1 
adjusted) 
 (IC 95%) 
1.00 
 
1.09 
(0.86-1.38) 
0.95 
(0.74-1.21) 
1.01 
(0.80-1.29) 
0.85 1.00 
 
1.00 
(0.65-1.54) 
1.11 
(0.73-1.68) 
1.27 
(0.85-1.90) 
0.23 1.00 
 
0.88 
(0.59-1.32) 
0.80 
(0.53-1.21) 
0.71 
(0.46-1.08) 
0.09 
Cheese (g) <27.26 27.26-47.76 47.76-71.29 >71.29 P for 
trend 
<27.26 27.26-47.76 47.76-71.29 >71.29 P for 
trend 
<26.67 26.67-46.95 46.95-70.13 >70.13 P for 
trend 
Cases (n) 140 115 136 125  47 41 45 42  41 37 52 42  
RR (Age-adjusted) 
(IC 95%) 
1.00 
 
0.83 
(0.65-1.07) 
0.98 
(0.77-1.25) 
0.92 
(0.71-1.20) 
0.85 1.00 
 
0.91 
(0.60-1.39) 
1.01 
(0.67-1.54) 
1.01 
(0.64-1.59) 
0.87 1.00 
 
0.90 
(0.57-1.40) 
1.23 
(0.81-1.87) 
0.99 
(0.62-1.57) 
0.68 
RR (Fully1 
adjusted) 
 (IC 95%) 
1.00 
 
0.82 
(0.64-1.05) 
0.97 
(0.76-1.24) 
0.90 
(0.69-1.17) 
0.72 1.00 
 
0.89 
(0.58-1.36) 
0.99 
(0.65-1.50) 
0.98 
(0.62-1.55) 
0.96 1.00 
 
0.89 
(0.57-1.40) 
1.22 
(0.80-1.85) 
0.97 
(0.61-1.54) 
0.74 
1 Adjusted for the following variables at the time of dietary record: educational level, current smoking status, family history of colon cancer, body mass index, physical activity level and energy and 
alcohol intake. - 2Non-consumer. 
 
 
 Discussion  
 
Our ﬁndings support the hypothesis that intakes of total dietary calcium and phosphorus reduce 
the risk of colorectal tumour at all stages of the adenoma-carcinoma sequence, while dietary vitamin D 
does not appear to be associated with colorectal tumour risk. Our study also revealed a protective effect of 
dairy products consumption on the risk of colorectal tumours.  
Epidemiological data on the relationship between calcium and colorectal tumour risk are 
conﬂicting. A meta-analysis of 24 studies did not support a potential protective effect of calcium on col-
orectal tumours (cancer and/or adenoma) and emphasised the heterogeneity of the ﬁndings8. A review of 
over 20 case-control and cohort studies on colorectal cancer risk concluded that calcium had no protective 
effect.
7
 
However, our ﬁnding of a decrease in risk of colorectal cancer with a high intake of calcium was 
in agreement with recent studies. The ATBC trial,
24
 
using male smokers, observed a strong decrease in 
colorectal cancer risk in subjects with a high calcium intake (median of 4th quartile51,789 mg/day) 
compared to subjects with a low calcium intake (median of 1st quartile5856 mg/ day). In the Cancer 
Prevention Study II Nutrition (CPSN) cohort, a protective effect of total (i.e., supplemental and dietary) 
calcium was also observed in both men and women.
9
 
A recent pooled analysis
12
 
of 10 cohort studies (not 
including the CPSN cohort) found a signiﬁcant protective effect of calcium on colorectal cancer risk. 
Three case-control studies,
10,25,26
 
but not a fourth,
27 
found similar results, but 2 cohort studies
11,28
 
failed to 
conﬁrm them. Few studies have reported results on the association between calcium and risk of colorectal 
adenoma. Most of these
29-31
 found that calcium had nonsigniﬁcant protective effects or no effect. One 
found that calcium from a low-fat dairy product had a protective effect on the risk of large adenomas in 
men.
30
 
 
A recent review
7
 
and several recently published studies
9,10,24,25
 
concluded that dietary vitamin D 
had no protective effect on colorectal cancer, but it has been reported to have a slight protective effect on 
adenoma risk.
30,31
 
However, 2 of these studies
9,25
 
found a protective effect of total (i.e., supplemental and 
dietary) vitamin D on colorectal cancer. The lack of effect of dietary vitamin D in our population can be 
explained by the low dietary intake of vitamin D, as most dairy products available in France during the 
dietary assessment period were not vitamin-enriched. Detailed quantitative data on calcium and vitamin D 
supplementation are not available for our population.  
A slight protective effect of phosphorus on adenoma risk was previously observed in 1 case-
control study,
30
 
although it did not reach statistical signiﬁcance. However, calcium and phosphorus were 
strongly correlated in our population, making it difﬁcult to identify the effect of each mineral 
independently. The observed protective effect of phosphorus might be partially confounded by that of 
calcium, but the reverse is also possible.  
A recent review of epidemiological data
32
 
concluded that dairy products had a potential protective 
effect on adenoma occurrence. Another review revealed a consistent protective effect of dairy products on 
colorectal cancer occurrence in cohort studies but not in case-control studies.
6
 
The effect was not found in 
the CPSN cohort.
9
 
The analysis of the Pooling Project
12
 
(which did not include the CPSN cohort) revealed 
a lower risk of colorectal cancer in subjects who consumed over 250 g/day of dairy products than in those 
consuming under 70 g/day. However, the effect was restricted to cancers of the distal colon and the 
rectum.  
The mechanisms that are claimed to explain a potential protective effect of calcium, vitamin D 
and/or dairy products have recently been reviewed.
2,3,6
 
Newmark et al.
1
 
ﬁrst suggested in 1984 that ionised 
calcium might precipitate with secondary bile acids and fatty acids to generate insoluble soap, protecting 
the mucosa from their deleterious effect. Later, others
33
 
suggested that phosphorus might also be involved 
in this mechanism through the formation of calcium phosphate.  
Two intervention trials conducted on adenoma recurrence found a beneﬁcial effect13,15
 
of calcium 
supplementation, although it was signiﬁcant in only 1 trial.13
 
A more recent analysis found that a stronger 
beneﬁcial effect of calcium supplementation on the risk of recurrence with advanced neoplasms than with 
tubular adenomas.
14
 The effect was greater for subjects with a high dietary calcium intake. As far as the 
effect of vitamin D is concerned, experimental studies have shown that 1a,25-dihydroxyvitamin D3 might 
directly inhibit the proliferation of colonic cells and stimulate differentiation of a wide variety of cells, 
particularly colon cells, through the vitamin-D-receptor.
3
 
Some of these studies argued that the 
concentration of vitamin D receptors in cells might be greater than the levels of vitamin D.
3,6
 
Polymorphism of the vitamin D receptors could modulate the effect of both calcium and vitamin D.
3
 
Endogenous vitamin D synthesis is dependent on skin colour and sunshine exposure. Our data do not 
support a protective effect of dietary vitamin D. Further adjustment for sunshine exposure in our 
predominantly Caucasian population did not modify the ﬁndings.  
The prospective design of our study made it possible to avoid recall bias, which can lead to a 
misleading estimation of the effect of diet on colorectal tumour risk. Results of the validation study
18
 
for 
the dietary history questionnaire suggested a good quality of dietary data, attributable in large part to the 
high educational level of our volunteers and to their high degree of health consciousness. Furthermore, the 
response rate after 14 years of follow-up (85%) indicates the high degree of interest of participants and 
argues for the reliable quality of the recorded data. The exclusion of subjects in the top and bottom 1% of 
the energy intake/energy requirement ratio helped to reduce the impact of outliers on the estimation of 
risks.  
All cases of adenoma or cancer were histologically conﬁrmed, making it possible to correctly 
classify the subjects and to limit any decrease in power induced by false positives. Moreover, the use of 
polyp-free subjects as controls in the adenoma study limited the number of false negatives, i.e., controls 
bearing asymptomatic adenomas, the proportion of which exceeds 10% in women over 50 years of age.
34
 
In addition, women who undergo colonoscopy are a selected group, as demonstrated for example by a 
higher proportion of family history of colorectal cancer both in the polypfree group and in the adenoma-
free group as compared to the whole population. These 2 aspects underline the need for using polyp-free 
subjects recruited after a colonoscopy as controls for adenoma cases.  
Additional analyses were performed, omitting cases diagnosed during the ﬁrst year of dietary 
assessment. Findings were not subsequently changed but statistical signiﬁcance was not reached, because 
of decreased statistical power.  
The moderate associations observed in our study are at least in part attributable to the relatively 
short follow-up time, resulting in a small number of cases and a lack of statistical power. However, the 
shortness of the follow-up also limits changes in dietary habits, which are likely to occur in long 
prospective studies that fail to provide for updating of the dietary record. Another possible limitation 
derives from the homogeneity of our study population. Its narrow range of consumption levels and healthy 
dietary habits result in a relatively high intake of calcium and dairy products. Our population had a median 
calcium intake of approximately 1,000 mg, in agreement with the French guidelines
35
 
and the cut-off for 
the 1st quartile was 860 mg/ day). In the Cancer Prevention Study II Nutrition cohort,
9
 
the protective effect 
of total calcium was associated with intakes of over 1,255 mg/day compared to those of below 561 
mg/day. The analysis of the NHS and HPFS data,
11
 
both of which had an interquintile range of the same 
magnitude (<500 mg to >1,250 mg/day), also found a protective effect of calcium on distal cancer risk. In 
contrast, no calcium effect was found in the Finnish study, where calcium intake was high (bottom quar-
tile <1,178 mg). The authors of the Pooling Project
12
 
suggested a threshold effect for total calcium intake, 
with little further decrease in colorectal cancer risk for calcium intakes in excess of 1,000 mg/day, which 
agrees with our ﬁndings. We can therefore hypothesise that only low calcium intake is deleterious.  
Our data support an inverse association between calcium, phosphorus and dairy products and 
colorectal tumour risk. Further investigations should help to determine the optimum intakes for colorectal 
cancer prevention.  
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